Cargando…
Bacteriocin production by mucosal bacteria in current and previous colorectal neoplasia
BACKGROUND: Optimal therapy for colorectal carcinoma (CRC), a frequently diagnosed malignancy, does not exist. Some of colicins and microcins, ribosomally synthesized peptides by gramnegative bacteria, have shown significant biological activity specifically against different cancer cells in vitro an...
Autores principales: | Kohoutova, Darina, Forstlova, Miroslava, Moravkova, Paula, Cyrany, Jiri, Bosak, Juraj, Smajs, David, Rejchrt, Stanislav, Bures, Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966821/ https://www.ncbi.nlm.nih.gov/pubmed/31948419 http://dx.doi.org/10.1186/s12885-020-6512-5 |
Ejemplares similares
-
Escherichia colistrains of phylogenetic group B2 and D and bacteriocin production are associated with advanced colorectal neoplasia
por: Kohoutova, Darina, et al.
Publicado: (2014) -
Escherichia coli from biopsies differ in virulence genes between patients with colorectal neoplasia and healthy controls
por: Bosák, Juraj, et al.
Publicado: (2023) -
Role of S100 Proteins in Colorectal Carcinogenesis
por: Moravkova, Paula, et al.
Publicado: (2016) -
Anti-Outer membrane protein C and anti-glycoprotein 2 antibodies in inflammatory bowel disease and their association with complicated forms of Crohn’s disease
por: Kohoutova, Darina, et al.
Publicado: (2014) -
Tissue mRNA for S100A4, S100A6, S100A8, S100A9, S100A11 and S100P Proteins in Colorectal Neoplasia: A Pilot Study
por: Peterova, Eva, et al.
Publicado: (2021)